The Bustling Cell and Gene Therapy CMO Scene

The Bustling Cell and Gene Therapy CMO Scene

Pharma’s new and exciting era of targeted therapeutics has the potential to be a turning point for modern medicine. The buzz has led to a flurry of investment in the cell and gene therapy space. According to a recent Alliance for Regenerative Medicine report, nearly...
Viral Clearance Studies for Gene Therapies—Easier Said Than Done

Viral Clearance Studies for Gene Therapies—Easier Said Than Done

While incidents of biotherapeutic viral contamination have occurred, due to well-established knowledge of the potential sources of contamination and procedures to prevent it, the industry has an impressive track record. Biologics are susceptible to viral contamination...
Gene Therapy CMC & Manufacturing Approaches Are Maturing

Gene Therapy CMC & Manufacturing Approaches Are Maturing

The gene therapy sector is maturing and the industry is poised to be able to produce products in more consistent and scalable ways. Although the COVID-19 pandemic caused some delays, on the whole, projects are moving forward as planned. I had the opportunity to speak...